Malignancy in the setting of the anti-synthetase syndrome

Journal of Clinical Rheumatology

Volumn 14, Issue 5, 2008, Pages 285-288

  Rozelle, Andrew ^a   Trieu, Sandy ^a   Chung, Lorinda ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Dermatomyositis; Interstitial lung disease; Malignancy

Indexed keywords

AZATHIOPRINE; CAPECITABINE; OXALIPLATIN; PREDNISONE; STEROID; ANTINUCLEAR ANTIBODY; JO 1 ANTIBODY; JO-1 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTISYNTHETASE SYNDROME; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; DERMATOMYOSITIS; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERSTITIAL LUNG DISEASE; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN EXAMINATION; ADENOCARCINOMA; ARTHRITIS; COLON TUMOR; COMORBIDITY; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; POLYMYOSITIS; SYNDROME;

ADENOCARCINOMA; ANTIBODIES, ANTINUCLEAR; ARTHRITIS; COMORBIDITY; DERMATOMYOSITIS; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; POLYMYOSITIS; SIGMOID NEOPLASMS; SYNDROME;

EID: 58949102457     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31817d116f     Document Type: Article

References (26)

1. Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357:96-100.
2. Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine. 1991;70:360-374.
3. Chen YJ, Wu CY, Shen JL. Predicting factors of malignancy in der-matomyositis and polymyositis: a case-control study. Br J Dermatol. 2001;144:825-831.
4. Ponyi A, Constantin T, Garami M, et al. Cancer-associated myositis: clinical features and prognostic signs. Ann N Y Acad Sci. 2005;1051:64 -71.
5. Williams H, Bigby M, Diepgen T, et al, eds. Evidence-Based Dermatology. 2nd ed. Blackwell Publishing; Hoboken, NJ: 2003.
6. Marie I, Hachulla E, Cherin P, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum. 2002;47:614-622.
7. Sparsa A, Liozon E, Herrmann F, et al. Routine versus extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients. Arch Dermatol. 2002;138:885-890.
8. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositisdermatomyositis- associated interstitial lung disease. Am J Respir Crit Care Med. 2001;164:1182-1185.
9. Hidano A, Torikai S, Uemura T, et al. Malignancy and interstitial pneumonitis as fatal complications in dermatomyositis. J Dermatol. 1992;19:153-160.
10. Holmes R, Black MM, Farebrother MJ, et al. Malignancy associated dermatomyositis with fibrosing alveolitis. Report of a case with a discussion of the management. Clin Exp Dermatol. 1980;5:415-420.
11. Kaneoka H, Sasatomi Y, Miyagi K, et al. A rare case of dermatomyositis associated with immune-complex type glomerulonephritis, idiopathic thrombopenic purpura, pulmonary fibrosis and lung cancer. Clin Exp Rheumatol. 2003;21:801-802.
12. Choi YS, Ryu KH, Kwon GY, et al. Ureteral cancer associated with dermatomyositis. Int J Urol. 2006;13:442-444.
13. Satoh H, Ohtsuka M, Yamashita YT, et al. Breast cancer shortly after the diagnosis of interstitial pneumonia associated with polymyositis. Oncol Rep. 2000;7:105-106.
14. Perlman SG, Barth WF. Polymyositis, breast carcinoma, and interstitial lung disease. J Rheumatol. 1980;7:348-352.
15. Watanabe C, Okubo Y, Ohi T, et al. A case of dermatomyositis associated with mechanic's hand. J Dermatol. 2000;27:711-716.
16. Respicio G, Shwaiki W, Abeles M. A 58-year-old man with anti-Jo-1 syndrome and renal cell carcinoma: a case report and discussion. Conn Med. 2007;71:151-153.
17. Hirakata M, Suwa A, Takada T, et al. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum. 2007;56:1295-1303.
18. Sordet C, Goetz J, Sibilia J. Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. Joint Bone Spine. 2006;73:646-654.
19. Sarkar K, Miller FW. Autoantibodies as predictive and diagnostic markers of idiopathic inflammatory myopathies. Autoimmunity. 2004; 37:291-294.
20. Chinoy H, Fertig N, Oddis CV, et al. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis. 2007;66:1345-1349.
21. Aisa Y, Yokomori H, Kashiwagi K, et al. Polymyositis, pulmonary fibrosis and malignant lymphoma associated with hepatitis C virus infection. Intern Med. 2001;40:1109-1112.
22. Watkins J, Farzaneh-Far R, Tahir H, et al. Jo-1 syndrome with associated poorly differentiated adenocarcinoma. Rheumatology. 2004;43: 389-390.
23. Bonnefoy O, Ferretti G, Calaque O, et al. Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis. Eur J Radiol. 2004;49:235-244.
24. Koh ET, Seow A, Ong B, et al. Adult onset polymyositis/dermatomy-ositis: clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis. 1993;52:857-861.
25. Nambu Y, Mouri M, Toga H, et al. Gender and underlying diseases affect the frequency of the concurrence of adult polymyositis/dermatomyositis and interstitial pneumonia. Chest. 1994;106:1931-1932.
26. Wang YT, Singh D, Poh SC. Diffuse interstitial pulmonary fibrosis, dermatomyositis and lung cancer-a case report. Singapore Med J. 1980;21:778-780.